Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery

INTRODUCTION: Advancement of novel anticancer drugs into clinical use is frequently halted by their lack of solubility, reduced stability under physiological conditions, and non-specific uptake by normal tissues, causing systemic toxicity. Their progress to use in the clinic could be accelerated by...

Descripción completa

Detalles Bibliográficos
Autores principales: Breen, Alastair F, Scurr, David, Cassioli, Maria Letizia, Wells, Geoffrey, Thomas, Neil R, Zhang, Jihong, Turyanska, Lyudmila, Bradshaw, Tracey D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901036/
https://www.ncbi.nlm.nih.gov/pubmed/31824148
http://dx.doi.org/10.2147/IJN.S226293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901036/
https://www.ncbi.nlm.nih.gov/pubmed/31824148
http://dx.doi.org/10.2147/IJN.S226293

Ejemplares similares